Review Article| Volume 361, ISSUE 4, P411-419, April 2021

Pulmonary Aspergillosis: Spectrum of Disease

Published:December 12, 2020DOI:


      Aspergillus species are ubiquitous in the environment. Aspergillosis is acquired by inhalation of Aspergillus spores. In normal hosts, spore inhalation rarely causes lung disease. Pulmonary Aspergillosis covers a wide spectrum of clinical syndromes depending on the interaction between Aspergillus and the host (immune-status, prior bronchopulmonary disease). It runs the gamut from invasive Aspergillosis to Aspergillus bronchitis. Invasive Aspergillosis usually occurs in severely immunocompromised patients, typically in neutropenic but also in non-neutropenic patients. Chronic pulmonary Aspergillosis affects patients with chronic structural lung disease such as COPD or previous mycobacterial lung disease, but without other significant immunocompromise. Aspergillus bronchitis affects patients with bronchial disease such as bronchiectasis. Allergic bronchopulmonary Aspergillosis affects patients with bronchial asthma or cystic fibrosis, and is due to an allergic response to Aspergillus.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Denning D.W.
        • Chakrabarti A.
        Pulmonary and sinus fungal diseases in non-immunocompromised patients.
        Lancet Infect Dis. 2017; 17: e357-ee66
        • Kosmidis C.
        • Denning D.W.
        The clinical spectrum of pulmonary aspergillosis.
        Thorax. 2015; 70: 270-277
        • Patterson K.C.
        • Strek M.E.
        Diagnosis and treatment of pulmonary aspergillosis syndromes.
        Chest. 2014; 146: 1358-1368
        • Kousha M.
        • Tadi R.
        • Soubani A.O.
        Pulmonary aspergillosis: a clinical review.
        Eur Respir Rev. 2011; 20: 156-174
        • Segal B.H.
        N Engl J Med. 2009; 360: 1870-1884
        • Meersseman W.
        • Lagrou K.
        • Maertens J.
        • et al.
        Invasive aspergillosis in the intensive care unit.
        Clin Infect Dis. 2007; 45: 205-216
        • De Pauw B.
        • Walsh T.J.
        • Donnelly J.P.
        • et al.
        Revised definitions of invasive fungal disease from the European organization for research and treatment of cancer/invasive fungal infections cooperative group and the national institute of allergy and infectious diseases mycoses study group (EORTC/MSG) consensus group.
        Clin Infect Dis. 2008; 46: 1813-1821
        • Hage C.A.
        • Carmona E.M.
        • Epelbaum O.
        • et al.
        Microbiological laboratory testing in the diagnosis of fungal infections in pulmonary and critical care practice. An official american thoracic society clinical practice guideline.
        Am J Respir Crit Care Med. 2019; 200: 535-550
        • Herbrecht R.
        • Denning D.W.
        • Patterson T.F.
        • et al.
        Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.
        N Engl J Med. 2002; 347: 408-415
        • Patterson T.F.
        • Thompson 3rd, G.R.
        • Denning D.W.
        • et al.
        Practice guidelines for the diagnosis and management of aspergillosis: 2016 update by the infectious diseases society of America.
        Clin Infect Dis. 2016; 63: e1-e60
        • Denning D.W.
        Commentary: unusual manifestations of aspergillosis.
        Thorax. 1995; 50: 812-813
        • Freifeld A.G.
        • Bow E.J.
        • Sepkowitz K.A.
        • et al.
        Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the infectious diseases society of America.
        Clin Infect Dis. 2011; 52: 427-431
        • Denning D.W.
        • Cadranel J.
        • Beigelman-Aubry C.
        • et al.
        Chronic pulmonary aspergillosis: rationale and clinical guidelines for diagnosis and management.
        Eur Respir J. 2016; 47: 45-68
        • Kravitz J.N.
        • Berry M.W.
        • Schabel S.I.
        • et al.
        A modern series of percutaneous intracavitary instillation of amphotericin B for the treatment of severe hemoptysis from pulmonary aspergilloma.
        Chest. 2013; 143: 1414-1421
        • Alshabani K.
        • Haq A.
        • Miyakawa R.
        • et al.
        Invasive pulmonary aspergillosis in patients with influenza infection: report of two cases and systematic review of the literature.
        Expert Rev Respir Med. 2015; 9: 89-96
        • Crum-Cianflone N.F.
        Invasive aspergillosis associated with severe influenza infections.
        Open Forum Infect Dis. 2016; 3 (ofw171)
        • Chrdle A.
        • Mustakim S.
        • Bright-Thomas R.J.
        • et al.
        Aspergillus bronchitis without significant immunocompromise.
        Ann N Y Acad Sci. 2012; 1272: 73-85
        • Agarwal R.
        • Chakrabarti A.
        • Shah A.
        • et al.
        Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria.
        Clin Exp Allergy. 2013; 43: 850-873
        • Agarwal R.
        • Sehgal I.S.
        • Dhooria S.
        • et al.
        Developments in the diagnosis and treatment of allergic bronchopulmonary aspergillosis.
        Expert Rev Respir Med. 2016; 10: 1317-1334
        • Lal A.
        • Akhtar J.
        • Pinto S.
        • et al.
        Recurrent pulmonary embolism and hypersensitivity pneumonitis secondary to aspergillus, in a compost plant worker: case report and review of literature.
        Lung. 2018; 196: 553-560
        • Meeker D.P.
        • Gephardt G.N.
        • Cordasco Jr., E.M.
        • et al.
        Hypersensitivity pneumonitis versus invasive pulmonary aspergillosis: two cases with unusual pathologic findings and review of the literature.
        Am Rev Respir Dis. 1991; 143: 431-436
        • Selman M.
        • Lacasse Y.
        • Pardo A.
        • et al.
        Hypersensitivity pneumonitis caused by fungi.
        Proc Am Thorac Soc. 2010; 7: 229-236
        • Raghu G.
        • Remy-Jardin M.
        • Ryerson C.J.
        • et al.
        Diagnosis of hypersensitivity pneumonitis in adults. An official ATS/JRS/ALAT clinical practice guideline.
        Am J Respir Crit Care Med. 2020; 202: e36-e69
        • Vasakova M.
        • Morell F.
        • Walsh S.
        • et al.
        Hypersensitivity pneumonitis: perspectives in diagnosis and management.
        Am J Respir Crit Care Med. 2017; 196: 680-689